<DOC>
	<DOCNO>NCT02775227</DOCNO>
	<brief_summary>Pancreatic resection carry high risk complication , especially pancreatic fistula . Both hydrocortisone pasireotide show effective reducing complication earlier RCTs . The aim study compare effectiveness safety two drug prevent complication pancreatic surgery .</brief_summary>
	<brief_title>Hydrocortisone vs. Pasireotide Preventing Pancreatic Surgery Complications</brief_title>
	<detailed_description />
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Pancreatic Fistula</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Patients schedule pancreatic surgery ( pancreaticoduodenectomy , distal pancreatectomy , enucleation , type pancreatic resection ) Preoperative exclusion criterion : Atrophic pancreas and/or dilate pancreatic duct site plan pancreatic transsection ( apply patient undergo pancreaticoduodenectomy ) Total pancreatectomy plan Allergy contraindication hydrocortisone pasireotide Age &lt; 18 year No informed consent Intraoperative exclusion criterion : Pancreatic resection cancel ( e.g . disseminated cancer ) Hard pancreas and/or dilate pancreatic duct discover operation ( apply patient undergo pancreaticoduodenectomy ) Total pancreatectomy perform</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>